The US FDA issues best practices for communicating cybersecurity vulnerabilities to patient
The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) published best practices for communicating cybersecurity vulnerabilities to patients. The document provides information for the FDA, federal partners, and industry stakeholders to inform patients and the public about cybersecurity vulnerabilities. The paper highlights the following points: (1) make the content accessible (timely, relevant, simple, and readable) for people to read and understand; (2) discuss risks and benefits; (3) acknowledge and explain the unknown; (4) make it easy for patients to find and use information in online searches, and mobile devices.
About author
DW Team
The GIP Digital Watch Observatory team, consisting of over 30 digital policy experts from around the world, excels in the fields of research and analysis on digital policy issues. The team is backed by the creative prowess of Creative Lab Diplo and the technical expertise of the Diplo tech team.
